THERALASE TECHNOLOGIES INC /FI
through Aug 31, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | May 27, 2026 · D | Aug 31, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $262,156 | $168,695 | $-93,461 |
| Reported amount sold | $109,080 | $72,298 | $-36,782 |
| Reported investor count | 1 | 1 | 0 |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001062993-26-002887 · Later SEC source: 0001062993-26-004733
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $168,695
- Reported amount sold
- $72,298
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001062993-26-004733D · Aug 31, 2026 · OtherOffering: $168,695Sold: $72,298
-
0001062993-26-002887D · May 27, 2026 · OtherOffering: $262,156Sold: $109,080